Abstract
Background: RNA interference (RNAi) has emerged as one of the most extensively explored areas of research that has promising applications in therapeutics. As an endogenous regulatory pathway, RNAi can be used for silencing targeted genes involved in the progression of diseases. Small interfering RNAs (siRNA) are 21-25 nucleotides in length and work on the principle of RNA interference. Owing to their high degree of safety, specificity, efficacy, easy synthesis and unrestricted choice of target, siRNAs are considered appropriate for gene silencing.
Objective: This review discusses siRNA gene silencing mechanism, the challenges posed in siRNA delivery and the strategies developed to overcome some of these hurdles using nanocarriers. A few applications of siRNA in therapeutics are presented to highlight the utility of these strategies.
Conclusion: In spite of advantages of siRNA technology, several shortcomings such as off-target effects, hurdles in delivering, endosomal trapping, stimulation of immune response and short half-life limit the practical use of siRNA. However, the situation has been improved considerably using nanotechnology based tools.
Keywords: Nanocarriers, RNA interference, siRNA, challenges, delivery strategies, non-viral vectors.
Graphical Abstract
Pharmaceutical Nanotechnology
Title:SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications
Volume: 3 Issue: 4
Author(s): Prajakta Tambe, Pramod Kumar, Virendra Gajbhiye and K. M. Paknikar
Affiliation:
Keywords: Nanocarriers, RNA interference, siRNA, challenges, delivery strategies, non-viral vectors.
Abstract: Background: RNA interference (RNAi) has emerged as one of the most extensively explored areas of research that has promising applications in therapeutics. As an endogenous regulatory pathway, RNAi can be used for silencing targeted genes involved in the progression of diseases. Small interfering RNAs (siRNA) are 21-25 nucleotides in length and work on the principle of RNA interference. Owing to their high degree of safety, specificity, efficacy, easy synthesis and unrestricted choice of target, siRNAs are considered appropriate for gene silencing.
Objective: This review discusses siRNA gene silencing mechanism, the challenges posed in siRNA delivery and the strategies developed to overcome some of these hurdles using nanocarriers. A few applications of siRNA in therapeutics are presented to highlight the utility of these strategies.
Conclusion: In spite of advantages of siRNA technology, several shortcomings such as off-target effects, hurdles in delivering, endosomal trapping, stimulation of immune response and short half-life limit the practical use of siRNA. However, the situation has been improved considerably using nanotechnology based tools.
Export Options
About this article
Cite this article as:
Tambe Prajakta, Kumar Pramod, Gajbhiye Virendra and Paknikar M. K., SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications, Pharmaceutical Nanotechnology 2015; 3 (4) . https://dx.doi.org/10.2174/2211738504666160213001419
DOI https://dx.doi.org/10.2174/2211738504666160213001419 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations
Current Pharmacogenomics and Personalized Medicine High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes
Current Vascular Pharmacology A Palliative Care Approach to the Advanced Heart Failure Patient
Current Cardiology Reviews Inducible Nitric Oxide Synthase as a Possible Target in Hypertension
Current Drug Targets Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease
Current Pharmaceutical Design Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Blood Pressure Variability/Dipper/Non-dipper in Hypertension and Diabetes
Current Hypertension Reviews Editorial Statins: [Hot Topic: Statins: Effects Beyond Cholesterol Lowering (Guest Editor: Garry X. Shen)]
Current Drug Targets - Cardiovascular & Hematological Disorders Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design New Foods, New Consumers: Innovation in Food Product Development
Current Nutrition & Food Science Peripheral Arterial Disease and Oxidative Stress
Vascular Disease Prevention (Discontinued) Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
Current Pharmaceutical Design The Cost-Effectiveness of Palivizumab in the Prevention of Respiratory Syncytial Virus Bronchiolitis: A Systematic Review
Current Respiratory Medicine Reviews Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets